Private Wealth Management Group’s Biogen BIIB Stock Holding History

Private Wealth Management Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.6K	Buy	72 +20	+38%	+$3.83K	﹤0.01%	453
2026 Q1	$9.53K	Hold	52	–	–	﹤0.01%	540
2025 Q4	$9.15K	Sell	52 -2	-4%	-$327	﹤0.01%	539
2025 Q3	$7.57K	Buy	54 +7	+15%	+$946	﹤0.01%	621
2025 Q2	$5.9K	Sell	47 -60	-56%	-$7.48K	﹤0.01%	688
2025 Q1	$14.6K	Buy	107 +20	+23%	+$2.86K	0.01%	367
2024 Q4	$13.3K	Sell	87 -19	-18%	-$3.21K	0.01%	400
2024 Q3	$20.5K	Sell	106 -6	-5%	-$1.25K	0.01%	280
2024 Q2	$26K	Buy	112 +71	+173%	+$15.4K	0.01%	235
2024 Q1	$8.84K	Sell	41 -30	-42%	-$7.03K	﹤0.01%	444
2023 Q4	$18.4K	Buy	+71	New	+$17.4K	0.01%	276

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Private Wealth Management Group's BIIB Position: Q2 2026 in Review

Private Wealth Management Group increased its Biogen (BIIB) stake by 38% in Q2 2026, buying an estimated $3.83K and bringing the position to 72 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #453.

Private Wealth Management Group first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. The position peaked at $26K in Q2 2024. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Private Wealth Management Group held 72 shares of Biogen worth $15.6K as of Q2 2026.
Private Wealth Management Group bought 20 Biogen shares in Q2 2026, an estimated $3.83K.
Biogen made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #453 holding.
Private Wealth Management Group first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
Private Wealth Management Group's Biogen position peaked at $26K in Q2 2024.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.